12 KIT
Talking it out
More pumps and sensors 'talk' to each other, by
Martin Wilde.
There is increasing evidence
of diabetes technology
producers all over the world
successfully developing
insulin pumps and sensors that have
the ability to talk to each other -
interoperability - thereby creating an
automated insulin delivery system.
Here review the latest developments
being reported by each of the keep
manufacturers (in alphabetical order).
Beta Bionics
Beta Bionics has announced the US
launch of the iLet Bionic Pancreas
automated insulin delivery system
with the Dexcom G7 Continuous
Glucose Monitoring (CGM) System,
beginning December 18, 2023.
The iLet Bionic Pancreas is
an autonomous insulin delivery
system that streamlines diabetes
management and reduces the burden
on patients and physicians, partly
because the only input required to
get started is the user's weight -
the iLet does the rest. Healthcare
providers do not need to determine
complex settings such as correction
factors, insulin-to-carb ratios or
pre-set basal rates and, for iLet
users, there is no carb counting
or calculating insulin corrections
throughout the day, since the iLet
determines 100% of the insulin doses.
A new firmware update to the iLet
app (from the Apple App or Google
Play stores) means that users will be
able to update their iLet to integrate
with the Dexcom G7 (or Dexcom G6)
without any additional cost for new
hardware. This integration means
that users can use the iLet Bionic
Pancreas with what is claimed to be
the fastest and most accurate CGM
available. The Dexcom G7 features
an all-in-one sensor and transmitter
with only a 30-minute warmup
time when starting a new sensor.
It also enables users to share their
numbers with up to 10 people via the
iLet Beta Bionics on body
with Dexcom.